327 related articles for article (PubMed ID: 32675396)
21. Immunoreactivity of p53, Ki-67, and c-erbB-2 in phyllodes tumors of the breast in correlation with clinical and morphologic features.
Shpitz B; Bomstein Y; Sternberg A; Klein E; Tiomkin V; Kaufman A; Groisman G; Bernheim J
J Surg Oncol; 2002 Feb; 79(2):86-92. PubMed ID: 11815995
[TBL] [Abstract][Full Text] [Related]
22. Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins.
Tan PH; Thike AA; Tan WJ; Thu MM; Busmanis I; Li H; Chay WY; Tan MH;
J Clin Pathol; 2012 Jan; 65(1):69-76. PubMed ID: 22049216
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological significance of cancer stem cell markers CD44 and ALDH1 expression in breast cancer.
Louhichi T; Ziadi S; Saad H; Dhiab MB; Mestiri S; Trimeche M
Breast Cancer; 2018 Nov; 25(6):698-705. PubMed ID: 29845398
[TBL] [Abstract][Full Text] [Related]
24. Associations of epithelial c-kit expression in phyllodes tumours of the breast.
Tawasil J; Go EM; Tsang JY; Ni YB; Ko CW; Tse GM
J Clin Pathol; 2015 Oct; 68(10):808-11. PubMed ID: 26056158
[TBL] [Abstract][Full Text] [Related]
25. Characterization of cancer stem cells from different grades of human colorectal cancer.
Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers.
De Brot M; Rocha RM; Soares FA; Gobbi H
Pathology; 2012 Jun; 44(4):303-12. PubMed ID: 22544210
[TBL] [Abstract][Full Text] [Related]
27. Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.
Lugli A; Iezzi G; Hostettler I; Muraro MG; Mele V; Tornillo L; Carafa V; Spagnoli G; Terracciano L; Zlobec I
Br J Cancer; 2010 Jul; 103(3):382-90. PubMed ID: 20606680
[TBL] [Abstract][Full Text] [Related]
28. Plasma membrane proteomics of tumor spheres identify CD166 as a novel marker for cancer stem-like cells in head and neck squamous cell carcinoma.
Yan M; Yang X; Wang L; Clark D; Zuo H; Ye D; Chen W; Zhang P
Mol Cell Proteomics; 2013 Nov; 12(11):3271-84. PubMed ID: 23903875
[TBL] [Abstract][Full Text] [Related]
29. The Impact of Radiotherapy and Histological Risk Factors on Outcomes in Malignant Phyllodes Tumors.
Wong RX; Koh YS; Wong FY; Kusumawidjaja G; Ng WL; Yeo RMC; Farid M; Sheng Chan JY; Yan Z; Gudi MA; Tan PH
Clin Breast Cancer; 2020 Dec; 20(6):e695-e700. PubMed ID: 32636151
[TBL] [Abstract][Full Text] [Related]
30. Expression of EMT markers and mode of surgery are prognostic in phyllodes tumors of the breast.
Feng X; Zhao L; Shen H; Liu X; Yang Y; Lv S; Niu Y
Oncotarget; 2017 May; 8(20):33365-33374. PubMed ID: 28380418
[TBL] [Abstract][Full Text] [Related]
31. Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 cases.
Esposito NN; Mohan D; Brufsky A; Lin Y; Kapali M; Dabbs DJ
Arch Pathol Lab Med; 2006 Oct; 130(10):1516-21. PubMed ID: 17090194
[TBL] [Abstract][Full Text] [Related]
32. Phyllodes tumors of the breast: a case series of 106 patients.
Ben Hassouna J; Damak T; Gamoudi A; Chargui R; Khomsi F; Mahjoub S; Slimene M; Ben Dhiab T; Hechiche M; Boussen H; Rahal K
Am J Surg; 2006 Aug; 192(2):141-7. PubMed ID: 16860620
[TBL] [Abstract][Full Text] [Related]
33. B7-H3 and B7-H4 expression in phyllodes tumors of the breast detected by RNA in situ hybridization and immunohistochemistry: Association with clinicopathological features and T-cell infiltration.
Kim GE; Kim NI; Park MH; Lee JS
Tumour Biol; 2018 Nov; 40(11):1010428318815032. PubMed ID: 30486739
[TBL] [Abstract][Full Text] [Related]
34. Expression of CAF-Related Proteins Is Associated with Histologic Grade of Breast Phyllodes Tumor.
Kim HM; Lee YK; Koo JS
Dis Markers; 2016; 2016():4218989. PubMed ID: 27881889
[No Abstract] [Full Text] [Related]
35. Expression of vascular endothelial growth factor, CD10, and factor 8 in phyllodes tumor: A 5-year study of 38 cases.
Chaudhary D; Singh M; Kushwaha P; Agarwal R; Singh V; Mandal S; Khurana N; Mishra A
J Cancer Res Ther; 2020; 16(6):1408-1411. PubMed ID: 33342805
[TBL] [Abstract][Full Text] [Related]
36. Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers.
Bane A; Viloria-Petit A; Pinnaduwage D; Mulligan AM; O'Malley FP; Andrulis IL
Breast Cancer Res Treat; 2013 Jul; 140(1):195-205. PubMed ID: 23813303
[TBL] [Abstract][Full Text] [Related]
37. Malignant phyllodes tumor of the breast: a systematic review.
Lissidini G; Mulè A; Santoro A; Papa G; Nicosia L; Cassano E; Ashoor AA; Veronesi P; Pantanowitz L; Hornick JL; Rossi ED
Pathologica; 2022 Apr; 114(2):111-120. PubMed ID: 35414723
[TBL] [Abstract][Full Text] [Related]
38. ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder.
Keymoosi H; Gheytanchi E; Asgari M; Shariftabrizi A; Madjd Z
Asian Pac J Cancer Prev; 2014; 15(5):2013-20. PubMed ID: 24716927
[TBL] [Abstract][Full Text] [Related]
39. ALDH1 is an independent prognostic factor for patients with stages II-III rectal cancer after receiving radiochemotherapy.
Deng Y; Zhou J; Fang L; Cai Y; Ke J; Xie X; Huang Y; Huang M; Wang J
Br J Cancer; 2014 Jan; 110(2):430-4. PubMed ID: 24327017
[TBL] [Abstract][Full Text] [Related]
40. p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumors: a tissue microarray study.
Tan PH; Jayabaskar T; Yip G; Tan Y; Hilmy M; Selvarajan S; Bay BH
Mod Pathol; 2005 Dec; 18(12):1527-34. PubMed ID: 16258510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
